What are the signs of Mantle Cell Lymphoma recurrence and how is it monitored

Signs of Mantle Cell Lymphoma Recurrence and Monitoring

I'll explain what recurrence looks like and how your medical team watches for it after treatment.

What is Recurrence?

Recurrence (also called relapse) means mantle cell lymphoma returns after a period where it was in remission (no signs of cancer). This is different from refractory disease, which means the cancer never fully responded to initial treatment.

---

Signs of Recurrence to Watch For

According to the NCCN Guidelines for Mantle Cell Lymphoma, you should be alert to:

Physical Symptoms

• Swollen lymph nodes (in neck, underarms, groin, or abdomen) that you can feel or that your doctor notices
• Unexplained fatigue or weakness that's new or worsening
• Night sweats or fever
• Unintended weight loss
• Abdominal swelling or discomfort (from enlarged spleen or liver)
• Persistent cough or shortness of breath (if chest/lung involvement)

Important Note

Some patients have no symptoms at all—recurrence may only be detected on imaging or blood work during routine follow-up.

---

How Recurrence is Monitored

The NCCN Guidelines outline a structured surveillance approach:

During the First 2 Years After Treatment

• Clinical visits: Physical exam and blood work (CBC, comprehensive metabolic panel, LDH) every 3-6 months
• Imaging: CT scan of chest/abdomen/pelvis with contrast no more than every 6 months (or as clinically indicated)
• PET-CT scans: May be used if there's concern about recurrence

After 2 Years

• Clinical visits: Continue every 3-6 months for up to 5 years, then annually or as clinically indicated
• Imaging: Only as needed based on symptoms or clinical concern

What Doctors Look For on Imaging

According to the Lugano Response Criteria for Non-Hodgkin Lymphoma (the standard used to assess lymphoma):

Signs of recurrence include:

• New lymph nodes >1.5 cm in size
• Enlargement of previously treated nodes
• New areas of FDG uptake on PET scans (showing metabolic activity of cancer cells)
• Return of splenomegaly (enlarged spleen) or hepatomegaly (enlarged liver)
• Bone marrow involvement

---

Key Lab Values to Monitor

Your doctor will track:

• LDH (lactate dehydrogenase): Elevated levels can suggest disease activity
• CBC (complete blood count): Changes in white blood cells, hemoglobin, or platelets
• Beta-2-microglobulin: A protein that may indicate disease burden

---

Questions to Ask Your Oncology Team

To stay engaged in your monitoring plan:

1. "What specific symptoms should I report between appointments?" (This helps you know what's urgent vs. routine)

2. "How often will I have imaging scans, and what type?" (Understanding your schedule helps you prepare)

3. "What are my specific LDH and other baseline values, and what changes would concern you?" (Knowing your numbers helps you track trends)

4. "If recurrence is detected, what are my treatment options?" (According to NCCN Guidelines, options may include covalent BTK inhibitors, CAR T-cell therapy, or clinical trials—but your doctor determines what's right for your case)

5. "How long will I need surveillance monitoring?" (Typically 5 years minimum, sometimes longer)

---

Important Context

According to the NCCN Guidelines for Mantle Cell Lymphoma, the approach to recurrence depends on:

• How long remission lasted (early recurrence vs. late recurrence)
• Prior treatments received
• Your overall health and performance status
• Specific biomarkers (like TP53 mutation status)

Your oncologist will determine the most appropriate approach for YOUR specific situation based on the complete clinical picture.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.